Blog
RSS FeedPosted by Michael Wonder on 23 Oct 2025
New life saving medicine free for rare disease
22 October 2025 - Australians with the extremely rare and life-threatening inherited disease, acid sphingomyelinase deficiency (ASMD) will now have ...
Posted by Michael Wonder on 17 Oct 2025
Rare cancer lifeline comes with dual drug discounts
17 October 2025 - Two common immunotherapy drugs will now be subsidised for all advanced or metastatic cancers, providing a ...
Posted by Michael Wonder on 17 Oct 2025
Immunotherapy for patients with advanced cancers
17 October 2025 - More Australians living with advanced cancer could have access to immunotherapy treatment options, thanks to a ...
Posted by Michael Wonder on 16 Oct 2025
Recommendations made by the PBAC - September 2025
17 October 2025 - Recommendations made by the PBAC in September 2025 relating to the listing of medicines on the PBS ...
Posted by Michael Wonder on 10 Oct 2025
DUSC utilisation analysis public release documents (April 2025)
10 October 2025 - The utilisation analysis public release documents from the April 2025 DUSC meeting are now available. ...
Posted by Michael Wonder on 04 Oct 2025
Engaging stakeholders along health technology assessment pathways: a scoping review of international practice
30 September 2025 - Health technology assessment has been characterised as a complex adaptive system that centrally features stakeholder interactions. ...
Posted by Michael Wonder on 01 Oct 2025
Public prostate cancer patients told treatment provided by public hospitals no longer available
1 October 2025 - Men with aggressive prostate cancer who were being treated with a groundbreaking drug have been told ...
Posted by Michael Wonder on 30 Sep 2025
Schedule of Pharmaceutical Benefits - 1 October 2025
1 October 2025 - The October 2025 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 29 Sep 2025
New life changing medicines listed on the PBS
28 September 2025 - From 1 October 2025, Australians affected by breast cancer and rare kidney disease will have access ...
Posted by Michael Wonder on 27 Sep 2025
Major breast cancer treatment cost slashed under new PBS listing
28 September 2025 - Thousands of women will pay significantly less for treatment after the Federal Government listed a leading ...
Posted by Michael Wonder on 27 Sep 2025
Health Minister Mark Butler says PBS not for negotiation, Donald Trump announced 100 pc tariff on pharmaceutical goods
26 September 2025 - Health Minister Mark Butler says Australia’s PBS will be protected at all costs, despite a pending ...
Posted by Michael Wonder on 26 Sep 2025
Australia’s progress in genomic medicine too slow, says international health chief
27 September 2025 - An international genomics chief says Australia is slipping behind the rest of the world in genomic medicine ...
Posted by Michael Wonder on 25 Sep 2025
‘A brand new era in Alzheimer’s therapy’: drug cleared by regulator
24 September 2025 - Australia’s drug regulator has approved the registration of an amyloid-reducing therapy for Alzheimer’s disease after twice ...
Posted by Michael Wonder on 24 Sep 2025
Leqembi (lecanemab) approved for the treatment of Alzheimer’s disease in Australia
24 September 2025 - Eisai and Biogen announced today that the TGA of Australia has approved the humanised anti-soluble aggregated ...
Posted by Michael Wonder on 24 Sep 2025
Push for taxpayers to fund weight loss drugs for 500,000 Australians
23 September 2025 - Danish pharmaceutical giant Novo Nordisk has asked the Federal Government to subsidise its blockbuster weight loss ...